Company news

Fosun International Limited news in 2026

Fosun International Limited's news releases, calls and decks from 2026, newest first.

View company

Appointment of joint company secretary and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules

November 6, 2026

Monthly return as at 31 October 2026

November 4, 2026

Announcement - passing of joint company secretary

November 2, 2026

Announcement - principal financial data of fosun high technology for the nine months ended 30 September 2026

October 30, 2026

Announcement - principal financial data of yuyuan for the nine months ended 30 September 2026

October 29, 2026

Fosun International Wins Five Awards at The Asset Corporate Sustainability Leadership Awards 2026, Upgraded to Platinum

October 13, 2026

Monthly return as at 30 September 2026

October 6, 2026

List of directors and their roles and functions

September 24, 2026

Appointment of non-executive director

September 24, 2026

Interim report 2026

September 22, 2026

Club med inaugurates its first resort in south africa, pioneering a new beach & safari experience

September 21, 2026

ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application

September 8, 2026

Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record

September 7, 2026

Fosun International's Hang Seng Sustainability Rating Climbs to AA+, Setting a New Record

September 7, 2026

Fosun International Holds 2026 Interim Results Presentation: Unlocking Core Pathways, Accelerating Growth in Industries where we Excel

August 31, 2026

Fosun International: Henlius’ Serplulimab Approved for Perioperative Gastric Cancer, Pioneering a Chemotherapy-Sparring Adjuvant Approach

June 9, 2026

Fosun International: Henlius' Pertuzumab Approved in China, Solidifying Breast Cancer Strategy as the First China-US-EU Approved Chinese Trastuzumab-Pertuzumab Combination

May 28, 2026

Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease

May 14, 2026

Fosun International: Henlius’ HLX43 (anti-PD-L1 ADC) Receives PMDA’s Acknowledge to Initiate Global Phase 2/3 Trial in sqNSCLC

May 8, 2026

ESG Report 2025

April 28, 2026

Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%，Aiming to Achieve“RMB10 Billion in Profit”

March 30, 2026

Fosun International and HSBC China Sign Strategic Cooperation Agreement

March 13, 2026

Fosun Navigates Cyclical Volatility and Clears Risks as Management Reaffirms RMB10 Bn Profit Target for Next 3 to 5 Yrs

March 12, 2026

Fosun International: One-Off Non-Cash Impairment Provisions for Certain Non-Core Businesses, Core Industries Maintain Sound Development Momentum

March 9, 2026

Fosun International Receives “Certificate of Excellence in Environmental, Social and Governance Reporting” from Hong Kong Management Association

February 26, 2026

Decks in 2026